BackBlueprint Medicines Overview

Blueprint Medicines Inventory

Blueprint Medicines's inventory is $13M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$12.95M
58.14% YoYΔ $-17.99M vs prior year quarter

Peer trimmed avg / median

Loading

Blueprint Medicines Inventory History

Loading

Blueprint Medicines vs. peers: Inventory Comparison

Loading

Blueprint Medicines Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Blueprint Medicines (BPMC) FAQ

As of the most recent data (March 2025), BPMC shows a inventory of $13M. That compares with $31M in the prior-year period — down 58.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BPMC's inventory is now $13M (was $31M) — a 58.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Blueprint Medicines is outperforming or lagging.

Tracking BPMC's inventory over time shows whether Blueprint Medicines is scaling, shrinking, or reshaping that part of the business. The current reading is $13M That compares with $31M in the prior-year period — down 58.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Blueprint Medicines's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $13M) with ownership activity and broader fundamentals.

Blueprint Medicines's inventory is $13M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.